
Quarterly report 2025-Q4
added 02-13-2026
FONAR Corporation Market Cap 2011-2026 | FONR
As of March 04, 2026 FONAR Corporation has a market cap of $ 121 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 85.2 M | 91.1 M | 158 M | 154 M | 163 M | 170 M | 144 M | 64.3 M | 68 M | 35.5 M | 20.3 M | 10.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 170 M | 10.4 M | 97 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 39.27 | -1.36 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
661 M | $ 7.82 | - | $ 561 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 3.99 | - | $ 149 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 9.4 | - | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 43.41 | - | $ 1.35 B | ||
|
Electromed
ELMD
|
175 M | $ 23.98 | - | $ 203 M | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 29.83 | - | $ 1.37 B | ||
|
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.17 | -3.35 % | $ 110 M | ||
|
InMode Ltd.
INMD
|
928 M | $ 13.6 | - | $ 879 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.43 | 1.42 % | $ 23.1 M | ||
|
IRadimed Corporation
IRMD
|
670 M | $ 104.29 | - | $ 1.32 B | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
160 M | $ 0.53 | - | $ 54.5 M | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
135 M | - | 10.28 % | $ 55.5 M | ||
|
LivaNova PLC
LIVN
|
3.81 B | $ 68.43 | -2.62 % | $ 3.73 B | ||
|
Pulmonx Corporation
LUNG
|
341 M | $ 1.53 | - | $ 59.8 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.8 | 6.81 % | $ 43.5 M | ||
|
Align Technology
ALGN
|
13.9 B | $ 182.64 | - | $ 13.7 B | ||
|
Medtronic PLC
MDT
|
111 B | $ 96.71 | - | $ 124 B | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
3.07 B | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
766 M | $ 3.68 | - | $ 779 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
196 B | $ 113.61 | - | $ 198 B | ||
|
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
213 M | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 73.85 | - | $ 109 B |